Ligand Pharmaceuticals Incorporated
About Ligand Pharmaceuticals Incorporated
Products & Services
Specialties
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Convertible Debt T: - FT: Convertible Debt |
A: 460000000 MR: - FA: 460.0 million FAN: 460000000 |
D: 2025-08-14 FD: 2025-08-14 |
- |
| 2 |
RT: Debt T: - FT: Debt |
A: 400000000 MR: - FA: $400.0 million FAN: 400000000 |
D: 2025-08-11 FD: 2025-08-11 |
- |
Growth Metrics
Team & Leadership
Todd Davis
Chief Executive Officer
Tavo Espinoza
Chief Financial Officer
Andrew Reardon
Chief Legal Officer
Vince Antle
Senior Vice President, Technical Operations and Quality Assurance
Richard Baxter
Senior Vice President, Investment Operations
Paul J. Hadden
Senior Vice President, Investments and Business Development
Recent News
Ligand Pharmaceuticals Incorporated Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Key Competitors
Competitor Alpha
Series B · $50M raised
Competitor Beta
Series C · $120M raised
Competitor Gamma
Series A · $25M raised
Competitor Delta
Seed · $10M raised
Company Details
- Website
- ligand.com
- Industries
- Biopharmaceuticals / Healthcare
- Company Size
- ~380 employees (est.)
- Locations
-
JUPITER, Fla.
Jupiter, Florida
Similar Companies
Discover AI-powered company recommendations based on industry, funding, and team profiles.
Upgrade to ProTechnology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro